wire - news in brief
Category
Results 101 - 150 of 390.
Computer scientist David Dao develops intelligent algorithms that use satellite and drone images of rainforests to predict where the next sites of deforestation will be.
Animal development is a unidirectional process that steers undifferentiated cells of the early embryo into specialized cell types such as brain, muscle or skin cells. Once differentiated, there is almost no way back. A notable exception is the de-differentiation of mature into immature cell types during injured tissue regeneration.
FDA approves Roche’s Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer
Approval based on the Phase III IMpower130 study showing the Tecentriq plus chemotherapy combination demonstrated a significant overall survival and progression-free survival benefit Roche today anno
Approval based on the Phase III IMpower130 study showing the Tecentriq plus chemotherapy combination demonstrated a significant overall survival and progression-free survival benefit Roche today anno
Climate change not only affects the environment, but also has significant consequences on global health.
Proteomics pioneer Ruedi Aebersold is retiring soon. Protein analysis was his life's work, and he paved the way for countless protein researchers around the world.
Novartis breadth of data at 2019 ASH demonstrates commitment to reimagining medicine in hematology through innovative therapeutic platforms
Patients & Caregivers Healthcare Professionals Society & ESG With more than 140 abstracts, Novartis continues its leadership in hematology innovation Data for MBG453, an innovative anti-TIM
Patients & Caregivers Healthcare Professionals Society & ESG With more than 140 abstracts, Novartis continues its leadership in hematology innovation Data for MBG453, an innovative anti-TIM
"100 women and 1000 more": Sara Greco
Causal Effects of Brevity on Style and Success in Social Media Faculty of Informatics Open lecture of the course Argumentation in Conflict Resolution Visiting Alumni: Loredana Padurean, Associate Dean, Asia School of Business «Quel ramo del lago di Como...».
Causal Effects of Brevity on Style and Success in Social Media Faculty of Informatics Open lecture of the course Argumentation in Conflict Resolution Visiting Alumni: Loredana Padurean, Associate Dean, Asia School of Business «Quel ramo del lago di Como...».
Every year, 1.5 million people die from tuberculosis (TB) worldwide. Diagnosis and treatment is particularly difficult in remote rural areas.
Positive phase III results for Roche’s satralizumab in neuromyelitis optica spectrum disorder published in the New England Journal of Medicine
Satralizumab demonstrated robust efficacy, sustained for 144 weeks, in significantly reducing the risk of relapse in combination with baseline immunosuppressant therapy Satralizumab targets the interleukin-6 (IL-6) receptor, a potential key driver of neuromyelitis optica spectrum disorder (NMOSD) NMOSD is a rare, debilitating autoimmune disease of the central nervous system that can cause visual impairment, motor disability and even death Roche
Satralizumab demonstrated robust efficacy, sustained for 144 weeks, in significantly reducing the risk of relapse in combination with baseline immunosuppressant therapy Satralizumab targets the interleukin-6 (IL-6) receptor, a potential key driver of neuromyelitis optica spectrum disorder (NMOSD) NMOSD is a rare, debilitating autoimmune disease of the central nervous system that can cause visual impairment, motor disability and even death Roche
ESA Ministerial Council Meeting: Switzerland to participate in new programmes and play a leading role in the removal of space debris
On 27 and 28 November 2019, State Secretary Martina Hirayama attended the European Space Agency's ESA Ministerial Council meeting in Seville ("Space 19+").
On 27 and 28 November 2019, State Secretary Martina Hirayama attended the European Space Agency's ESA Ministerial Council meeting in Seville ("Space 19+").
Anyone who wants to open a bank account or buy a mobile phone plan has to identify themselves to the respective service provider.
The crew of the International Space Station has taken delivery of a haptic interface designed by EPFL spin-off Force Dimension. Astronauts could one day use the device, based on the famous delta robot developed at EPFL by Reymond Clavel, to control unmanned Martian and lunar rovers from afar. In a project called METERON, the European Space Agency (ESA) is exploring how advanced robots could be used to repair satellites in orbit or probe hostile environments like the Martian and lunar surfaces.
Greenhouse gases are the cause of climate change. The European infrastructure network ICOS (Integrated Carbon Observation System) is committed to standardised measurements so that emissions can be compared across Europe.
Media conference "Launch of the CHEOPS mission"
For the time being, the Swiss space telescope CHEOPS is scheduled to begin its journey into space in mid-December on board a Soyuz rocket from the European Space Agency (ESA) in Kourou, French Guiana.
For the time being, the Swiss space telescope CHEOPS is scheduled to begin its journey into space in mid-December on board a Soyuz rocket from the European Space Agency (ESA) in Kourou, French Guiana.
FDA grants priority review to Roche’s risdiplam for spinal muscular atrophy
Filing submission includes 12-month data from pivotal FIREFISH and SUNFISH trials in a broad population of people living with Types 1, 2 or 3 SMA Roche today announced that the U.S. Foo
Filing submission includes 12-month data from pivotal FIREFISH and SUNFISH trials in a broad population of people living with Types 1, 2 or 3 SMA Roche today announced that the U.S. Foo
Juhan Aru is a new professor in Mathematics at EPFL where he holds the Chair of Random Geometry. His work aims at understanding geometric properties of models where randomness and geometry meet.
Roche presents pivotal data demonstrating Tecentriq in combination with Avastin improves overall survival in people with the most common form of liver cancer
First Phase III cancer immunotherapy study to show an improvement in overall survival and progression-free survival in people with unresectable hepatocellular carcinoma compared with sorafenib Result
First Phase III cancer immunotherapy study to show an improvement in overall survival and progression-free survival in people with unresectable hepatocellular carcinoma compared with sorafenib Result
This year Renana Gershoni-Poranne was awarded a Branco Weiss Fellowship. The ETH chemist will use the research grant to design innovative compounds that can be used in future generations of electronic devices.
Empa scientist Mark Schubert and his team would like to use the many opportunities offered by machine learning for wood technology applications. Together with Swiss Wood Solutions, Schubert will present his latest project at the Swiss Innovation Forum on 21 November in Basel. Wood is a natural material that is lightweight and sustainable, with excellent physical properties, which make it an excellent choice for constructing a wide range of products with high quality requirements - for example for musical instruments and sports equipment.
EPFL hosts a new SBB innovation unit
Swiss Federal Railways (SBB) opened a new innovation unit today at EPFL's Innovation Park, further deepening its ties with the School.
Swiss Federal Railways (SBB) opened a new innovation unit today at EPFL's Innovation Park, further deepening its ties with the School.
Roche to present new and updated data for seven approved and investigational medicines across multiple types of breast cancer at the 2019 San Antonio Breast Cancer Symposium
Study results reflect advancements in HER2-positive, triple-negative, and hormone receptor-positive breast cancer Follow-up data from pivotal phase III APHINITY study evaluating Perjeta plus Hercepti
Study results reflect advancements in HER2-positive, triple-negative, and hormone receptor-positive breast cancer Follow-up data from pivotal phase III APHINITY study evaluating Perjeta plus Hercepti
The first-ever image of a black hole was unveiled to the public this past April. It was produced by a team of 200 scientists as part of the Event Horizon Telescope Project.
Novartis PARAGON-HF analyses suggest Entresto benefit beyond HFrEF
Patients & Caregivers Healthcare Professionals Society & ESG Entresto (sacubitril/valsartan) demonstrated greatest benefit in HFpEF patients with ejection fractions adjacent to HFrEF, compare
Patients & Caregivers Healthcare Professionals Society & ESG Entresto (sacubitril/valsartan) demonstrated greatest benefit in HFpEF patients with ejection fractions adjacent to HFrEF, compare
New Novartis medicine Adakveo (crizanlizumab) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
Patients & Caregivers Healthcare Professionals Society & ESG Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications 1 Adakveo reduced the an
Patients & Caregivers Healthcare Professionals Society & ESG Sickle cell pain crises are unpredictable, severe events associated with life-threatening complications 1 Adakveo reduced the an
Novartis receives positive CHMP opinion for Mayzent (siponimod) for the treatment of adult patients with active secondary progressive multiple sclerosis (SPMS)
Patients & Caregivers Healthcare Professionals Society & ESG If approved, Mayzent (siponimod) will be the first and only oral treatment specifically indicated for patients with active seconda
Patients & Caregivers Healthcare Professionals Society & ESG If approved, Mayzent (siponimod) will be the first and only oral treatment specifically indicated for patients with active seconda
CHMP recommends conditional EU approval of Roche’s Polivy for people with previously treated aggressive lymphoma
First-in-class antibody-drug conjugate that specifically targets CD79b, a protein expressed in the majority of B-cells Targeted off-the-shelf treatment represents potential new option for people with
First-in-class antibody-drug conjugate that specifically targets CD79b, a protein expressed in the majority of B-cells Targeted off-the-shelf treatment represents potential new option for people with
CHMP recommends EU approval of Roche’s Kadcyla for the adjuvant treatment of people with HER2-positive early breast cancer with residual invasive disease after neoadjuvant treatment
Kadcyla cut the risk of disease recurrence or death by half compared to Herceptin in the adjuvant setting for specific patients with HER2-positive early breast cancer At three years, 88.3% of
Kadcyla cut the risk of disease recurrence or death by half compared to Herceptin in the adjuvant setting for specific patients with HER2-positive early breast cancer At three years, 88.3% of
EPFL researchers have developed a geothermal system for recovering the heat captured in basements, subway tunnels and underground parking garages.
